Real Operational Turnarounds. Real Bottom-Line Impact.
Case Study 1: Freeing Frozen Working Capital From Slow-Moving Inventory
Turning Frozen Inventory Into Working Capital for a Growth-Stage Consumer Brand
THE CHAOS
A consumer brand's planning process covered demand and production, but it wasn't yet built to manage cash. The company was carrying more than $3.6 million in inventory value, more than a lean operation needed, with a real share of it slow-moving, obsolete, short-dated, or damaged, and no formal process to catch that early or move it out before it lost value. Safety stock was set conservatively rather than against real service targets. The result: cash that could have funded growth, paid down debt, or covered a slow month sat frozen on the shelf instead, in product that wasn't moving and wasn't going to.THE BLUEPRINT
Elevate Operations rebuilt the S&OP process around cash discipline, not just demand and production planning. Safety stock levels were rightsized to real service targets using Pareto analysis to prioritize which SKUs justified investment, replacing defensive stock-building with data-driven targets. A formal reserve and disposition process was put in place for slow-moving, obsolete, short-dated, and damaged inventory, working through closeout sales, repackaging for promotional use, and write-downs when nothing else could recover the value. Supplier payment terms were reviewed as part of the same planning cycle instead of negotiated in isolation.THE TRANSFORMATION
Within 9 months, carried inventory value dropped from $3,647,258 to $2,280,344, freeing $1,366,914 in working capital, a 37% reduction. Inventory turnover reached and held a sustained 4 to 6 times per year, and $120,000 (11%) in obsolete inventory costs were eliminated annually. Cash that had been sitting frozen on the shelf became capital the business could actually deploy, the difference between inventory that turns into cash and inventory that becomes a write-off.
Case Study 2: Eliminating Retailer Compliance Fees Through Inventory & CMO Realignment
Reversing Chronic Stockouts and OTIF Penalties for a National Retailer Consumer Brand
THE CHAOS
A growth-stage consumer brand generating $5.2M in gross sales was quietly bleeding margin through the back door. Despite steady top-line demand, the brand was chronically out of stock across multiple retail partners, triggering $126,000, roughly 2.4% of gross sales, in OTIF (On-Time-In-Full) and non-compliance deductions in a single year, fees retailers considered fully justified given the brand's fill rate performance. The root cause wasn't one problem but five compounding ones: inconsistent sales forecasting, a widening cash flow gap, aging vendor payables creeping toward credit limits, an inventory mix bloated with slow-moving SKUs, and not enough supply committed to the products actually driving revenue. Each issue alone was manageable; together, they created a self-reinforcing cycle of stockouts, late fees, and strained vendor relationships.THE BLUEPRINT
Elevate Operations stepped in to rebuild the brand's planning and vendor infrastructure from the ground up. We overhauled the sales and operations planning process, rebuilding the forecast to reflect actual sell-through rather than legacy assumptions. We applied Pareto analysis across the full SKU portfolio to separate top-performing products from slow-moving inventory, redirecting production priority and cash toward the SKUs actually driving revenue. On the vendor side, we restructured the relationship with the CMO directly, negotiating a structured payment plan and establishing weekly forecast and production reviews with the CMO's team, while working in parallel with the CMO's CFO to pay down aging invoices and get the account back under its credit limit. Finally, we brought sales and customer-facing teams into the loop, proactively confirming ship dates with retail customers, rebuilding pipeline inventory across all distribution centers, and adjusting delivery timing in advance whenever a miss was likely, turning reactive firefighting into proactive customer communication.THE TRANSFORMATION
Within twelve months, the brand essentially eliminated OTIF and non-compliance fees entirely, turning a 2.4% drag on gross sales into a rounding error, while protecting retailer relationships that had been at real risk. Inventory turnover improved from 3 turns to 8 turns, freeing up substantial working capital previously trapped in slow-moving stock. Focusing production and cash on the highest-margin, highest-velocity SKUs improved overall net margins, while closer, more disciplined collaboration with the CMO shortened lead times and made the supply chain meaningfully more responsive. What had been a cycle of stockouts, penalties, and strained vendor trust became a stable, in-stock, better-margin operation, proof that compliance fees are rarely a "fulfillment problem" alone, but a symptom of forecasting, cash, and vendor-relationship issues working against each other.
Case Study 3: Global Tariff Insulation & Supply Chain Resilience
Orchestrating Multi-National Sourcing and Complex Logistical Networks for High-End Cosmetics
THE CHAOS
A scaling cosmetics brand faced severe margin erosion and unpredictable delivery timelines due to geopolitical tariff volatility and an over-reliance on a single-source overseas manufacturer. This strain was heavily compounded by an unaligned, multi-facility logistical footprint. The brand struggled to balance volatile production schedules and high-end component deliveries across a delicate vendor network spanning China, Canada, and the USA, all while routing premium packaging and inventory through an intricate mix of in-house manufacturing, external Contract Manufacturers (CMOs), and regional 3PL overflow warehouses.THE BLUEPRINT
Elevate Operations engineered and executed an aggressive global nearshoring and vendor diversification initiative. We stepped in to tightly coordinate with internal production teams, mapping out a rigid material-flow matrix that balanced raw component arrivals with actual assembly lines and retail sales demand. Concurrently, we systematically migrated premium packaging and manufacturing portfolios away from high-tariff zones, leveraging strategic free trade regions across North America to shield the supply chain from fluctuating international trade penalties.THE TRANSFORMATION
Successfully mitigated severe tariff penalties by establishing low-duty nearshore networks, keeping overall landed costs lower than tariffed baselines. While broader macroeconomic pressures still impacted net margins, our strategic inventory management secured continuous product flow, slashing total supply chain lead times by 50% and minimizing product volume trapped in the pipeline. By reducing total inventory investment, we unlocked rapid packaging changeovers, expanded scheduling flexibility on the assembly line, and successfully qualified secondary backup suppliers to ensure uninterrupted retail market execution.
Case Study 4: Turning a Vendor Price Shock into Lasting Supply Chain Resilience
Overcoming Vendor Price Shocks Through Cross-Functional CMO Orchestration
THE CHAOS
A sudden, steep price increase on a core active ingredient, comprising 30% of the flagship product's formula, arrived within days and coincided with a rapid deterioration in the primary vendor relationship, putting continuity of supply at risk for the brand's number one national retail SKU. Because this was an FDA-regulated, drug-labeled product, any formulation change to reduce cost exposure legally required strict validation runs and a mandatory 3-month stability testing window (21 CFR 211.166) before commercial release.THE BLUEPRINT
Serving as the brand owner's lead Project Manager, Elevate Operations orchestrated an emergency pivot to a qualified backup CMO, protecting continuity for the brand's flagship SKU without missing a shipment. With dual-sourcing now established, we used the new vendor relationship as leverage to renegotiate pricing with the original vendor, repairing the relationship over time while executing a phased, three-stage reduction in the costly ingredient's formula usage over the following two years, each stage validated within FDA timelines.THE TRANSFORMATION
By pairing an emergency vendor pivot with disciplined dual-source negotiation and a phased formula optimization, we brought finished unit costs down from a peak of $3.26 to $2.39, a 26.7% reduction, while restoring a healthy, competitively-priced relationship with the original vendor. What began as a crisis response became a permanent structural advantage: the brand's most important SKUs now had a qualified backup supplier in place, eliminating the single-source risk that had created the vulnerability in the first place. The flagship SKU maintained uninterrupted distribution across major national retail and chain drug channels throughout, at one point running as low as two weeks of on-hand supply, without a single stock out, proving that a supply crisis and a cost crisis can be solved together, and that the resulting leverage can pay dividends long after the immediate threat has passed.
Case Study 5: Post-Acquisition Integration & Portfolio Transition
Navigating FDA-Compliant Manufacturing Transfer as an M&A Brand Liaison
THE CHAOS
Following a major brand acquisition, a company with in-house manufacturing capabilities needed to execute a highly complex operational migration, bringing external manufacturing entirely in-house under a razor-thin timeline with zero room for market disruption. The acquired portfolio consisted of FDA-regulated, OTC Drug Labeled products, and in accordance with 21 CFR Parts 210-211, the migration required a validated manufacturing transfer, full cGMP compliance, and formal sign-offs before commercial production could begin.THE BLUEPRINT
Serving as the specialized brand-owner liaison to the exiting Contract Manufacturers (CMOs), Elevate Operations managed the complex technical data transition. Over a strict 4-month timeline, we drove the critical extraction of proprietary formulas, raw component pricing matrices, manufacturing protocols, and validation documentation from the legacy CMO network, serving as the vital operational bridge delivering this comprehensive data pack directly to the acquiring company's internal transition teams to fuel their manufacturing transfer and line calibrations, all while coordinating inventory levels to safeguard continuous retail market fulfillment.THE TRANSFORMATION
We delivered the complete manufacturing and compliance data pack ahead of schedule, allowing the acquiring company's internal teams to execute the manufacturing transfer without a single day of regulatory or production delay. By acting as a precise technical bridge, we eliminated data gaps, prevented costly transition friction with the departing CMOs, and safeguarded vital retail revenue streams while the new in-house manufacturing lines were being formally certified.
Case Study 6: Global Quality Recovery
Navigating FDA Medical Device Compliance and Sub-Tier Quality Specifications in International Manufacturing
THE CHAOS
A major quality crisis emerged when finished product defect complaints began trending upward for a high-volume consumer goods line classified as an FDA Medical Device. Because operations were governed by strict cGMP guidelines, these mounting structural breakages threatened regulatory compliance and brand viability. The manufacturing ecosystem spanned a USA-based lumber mill in a national forest, an international manufacturing facility in mainland China, and final delivery back to a USA distribution center for retail shipping. Hindered by language barriers, a 12-hour time difference, and an adversarial culture of inter-vendor blame, the factory and the raw material supplier reached a total operational standstill while defects mounted.THE BLUEPRINT
Rather than managing the crisis from a desk, Elevate Operations embedded directly at both source locations to enforce cGMP rigor. We traveled to the national forest and mill to uncover hidden material constraints, revealing that optimal product structural integrity required tight-ring inner heartwood harvested strictly during winter. We then flew to China, spending a week on the production floor to overhaul the quality control ecosystem. Based on our findings, we completely rewrote the physical engineering specifications for moisture levels, grain direction, and dimensional tolerances. To ensure these specs were strictly followed, we designed and deployed real-time go/no-go gauges during in-process quality checks and established rigid incoming raw material inspection reports. Finally, we institutionalized a mandatory Certificate of Conformance (CoC) system requiring Tier 2 and Tier 3 sub-tier suppliers to certify all materials prior to shipment, all while syncing production to a new 12-month rolling forecast cadence.THE TRANSFORMATION
The finger-pointing stopped, and a fully compliant, high-performing partnership was born. By implementing standardized test gates and sub-tier verification loops, the lumber mill stabilized its procurement and the factory in China permanently reversed its product defect trendline. This comprehensive operational turnaround restored absolute cGMP compliance, safeguarded retail customer trust, eliminated the threat of regulatory actions, and positioned the brand's physical infrastructure to scale rapidly.